Citadel Advisors’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14M Buy
35,000
+300
+0.9% +$9.84K ﹤0.01% 7363
2025
Q4
$1.1M Buy
34,700
+18,800
+118% +$565K ﹤0.01% 7178
2025
Q3
$374K Buy
+15,900
New +$272K ﹤0.01% 9833
2025
Q2
Sell
-2,900
Closed -$19.3K 14979
2025
Q1
$19.3K Sell
2,900
-100
-3% -$932 ﹤0.01% 13170
2024
Q4
$33.1K Sell
3,000
-3,600
-55% -$44.2K ﹤0.01% 12778
2024
Q3
$81.1K Sell
6,600
-4,700
-42% -$66.6K ﹤0.01% 11393
2024
Q2
$153K Sell
11,300
-38,500
-77% -$520K ﹤0.01% 10324
2024
Q1
$672K Buy
49,800
+48,900
+5,433% +$296K ﹤0.01% 7747
2023
Q4
$4.73K Sell
900
-300
-25% -$1.28K ﹤0.01% 13487
2023
Q3
$4.73K Sell
1,200
-9,200
-88% -$60.5K ﹤0.01% 13457
2023
Q2
$111K Sell
10,400
-1,400
-12% -$14.9K ﹤0.01% 10779
2023
Q1
$98.3K Sell
11,800
-3,400
-22% -$30.7K ﹤0.01% 11292
2022
Q4
$140K Buy
+15,200
New +$158K ﹤0.01% 10715
2021
Q4
Sell
-13,200
Closed -$336K 14722
2021
Q3
$336K Sell
13,200
-600
-4% -$16.7K ﹤0.01% 10808
2021
Q2
$465K Buy
13,800
+1,300
+10% +$46K ﹤0.01% 10211
2021
Q1
$486K Sell
12,500
-2,600
-17% -$148K ﹤0.01% 9741
2020
Q4
$935K Buy
15,100
+700
+5% +$32.1K ﹤0.01% 6936
2020
Q3
$482K Buy
+14,400
New +$411K ﹤0.01% 7368

Other funds holding STOK